Notice: Global Information Announces Listing on JASDAQ Standard Market of the Tokyo Stock Exchange

Cover Image
Market Research Report

Global Digital Genome Market Forecast 2021-2028

Published by Inkwood Research Product code 991382
Published Content info 208 Pages
Delivery time: 2-3 business days
Price
Back to Top
Global Digital Genome Market Forecast 2021-2028
Published: March 1, 2021 Content info: 208 Pages
Description

KEY FINDINGS

The global digital genome market is set to record a CAGR of 9.43% during the forecast period, 2021-2028. The rising investment in genomics by governments and manufacturers, the increasing prevalence of chronic diseases, and technological advancements, are projected to propel the market growth.

MARKET INSIGHTS

The digital genome deals with genes and their functions. It is a set of genetic material in a cell. It aids in finding causes of chronic disorders and resolves them. There is a surge in chronic diseases worldwide. Twin studies have established genes as major contributors to chronic conditions like depression, diabetes, obesity, cardiovascular disease, RA, Alzheimer's disease (AD), etc. As per the WHO (World Health Organization), around 48800 died in the UK in 2015, due to chronic diseases. The hectic lifestyle has given rise to diabetes and conditions like acute myocardial infarction, angina pectoris, and atherosclerosis. According to the WHO, chronic diseases pose a massive global challenge, accounting for almost 60% of all deaths worldwide. The rising prevalence has resulted in the increased use of the digital genome to treat such conditions. In recent times, evaluating individual-level risks for chronic diseases using molecular genetic data has been enabled due to genetic sequencing. Such factors drive market growth.

REGIONAL INSIGHTS

The global digital genome market growth analysis entails the assessment of North America, Europe, Asia Pacific, and rest of world. The Asia Pacific is estimated to be the prominent region in terms of CAGR by 2028. The market prospects are attributed to the increasing investment and the advancing research & development in genomics.

COMPETITIVE INSIGHTS

The growing demand for digital genome has resulted in the entry of several pharmaceutical companies into the market for R&D purposes. Abbott Laboratories, BioMerieux SA, Agilent Technologies Inc, Bio-Rad Laboratories Inc, etc., are among the key players in the market.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Table of Contents
Product Code: 36133

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. KEY DRIVERS
    • 3.1.1. INCREASING FUNDING BY THE MANUFACTURERS AND GOVERNMENTS IN GENOMICS
    • 3.1.2. ADVANCEMENTS IN TECHNOLOGY
    • 3.1.3. SURGING PREVALENCE OF CHRONIC DISEASES
  • 3.2. KEY RESTRAINTS
    • 3.2.1. RISKS ASSOCIATED WITH SECURITY ISSUE OF DIGITAL GENOME
    • 3.2.2. LACK OF PROFESSIONALS WITH ADEQUATE KNOWLEDGE ABOUT THE GENOMIC TECHNOLOGY

4. KEY ANALYTICS

  • 4.1. PORTER'S FIVE FORCES ANALYSIS
    • 4.1.1. THREAT OF NEW ENTRY
    • 4.1.2. THREAT OF SUBSTITUTION
    • 4.1.3. BUYER'S POWER
    • 4.1.4. SUPPLIER'S POWER
    • 4.1.5. COMPETITIVE RIVALRY
  • 4.2. IMPACT OF COVID-19 ON DIGITAL GENOME MARKET
  • 4.3. OPPORTUNITY MATRIX
  • 4.4. VENDOR LANDSCAPE
  • 4.5. KEY INVESTMENT INSIGHTS

5. MARKET BY PRODUCT

  • 5.1. SEQUENCING AND ANALYZER INSTRUMENTS
  • 5.2. DNA/RNA ANALYSIS
  • 5.3. SEQUENCING AND ANALYSIS SOFTWARE
  • 5.4. SEQUENCING CHIPS
  • 5.5. SAMPLE PREP INSTRUMENTS

6. MARKET BY APPLICATION

  • 6.1. DIAGNOSTICS
  • 6.2. DRUG DISCOVERY
  • 6.3. ACADEMIC RESEARCH
  • 6.4. PERSONALIZED MEDICINE
  • 6.5. AGRICULTURAL
  • 6.6. OTHER APPLICATIONS

7. MARKET BY END-USER

  • 7.1. DIAGNOSTICS AND FORENSIC LABS
  • 7.2. ACADEMIC RESEARCH INSTITUTES
  • 7.3. HOSPITALS
  • 7.4. OTHER END-USERS

8. GEOGRAPHICAL ANALYSIS

  • 8.1. NORTH AMERICA
    • 8.1.1. MARKET SIZE & ESTIMATES
    • 8.1.2. KEY GROWTH ENABLERS
    • 8.1.3. KEY CHALLENGES
    • 8.1.4. KEY PLAYERS
    • 8.1.5. COUNTRY ANALYSIS
      • 8.1.5.1. THE UNITED STATES
      • 8.1.5.2. CANADA
  • 8.2. EUROPE
    • 8.2.1. MARKET SIZE & ESTIMATES
    • 8.2.2. KEY GROWTH ENABLERS
    • 8.2.3. KEY CHALLENGE
    • 8.2.4. KEY PLAYERS
    • 8.2.5. COUNTRY ANALYSIS
      • 8.2.5.1. GERMANY
      • 8.2.5.2. FRANCE
      • 8.2.5.3. THE UNITED KINGDOM
      • 8.2.5.4. ITALY
      • 8.2.5.5. RUSSIA
      • 8.2.5.6. BELGIUM
      • 8.2.5.7. POLAND
      • 8.2.5.8. REST OF EUROPE
  • 8.3. ASIA PACIFIC
    • 8.3.1. MARKET SIZE & ESTIMATES
    • 8.3.2. KEY GROWTH ENABLERS
    • 8.3.3. KEY CHALLENGE
    • 8.3.4. KEY PLAYERS
    • 8.3.5. COUNTRY ANALYSIS
      • 8.3.5.1. CHINA
      • 8.3.5.2. JAPAN
      • 8.3.5.3. AUSTRALIA & NEW ZEALAND
      • 8.3.5.4. INDIA
      • 8.3.5.5. SOUTH KOREA
      • 8.3.5.6. THAILAND
      • 8.3.5.7. INDONESIA
      • 8.3.5.8. VIETNAM
      • 8.3.5.9. REST OF ASIA PACIFIC
  • 8.4. REST OF WORLD
    • 8.4.1. MARKET SIZE & ESTIMATES
    • 8.4.2. KEY GROWTH ENABLERS
    • 8.4.3. KEY CHALLENGE
    • 8.4.4. KEY PLAYERS
    • 8.4.5. REGIONAL ANALYSIS
      • 8.4.5.1. LATIN AMERICA
      • 8.4.5.2. MIDDLE EAST & AFRICA

9. COMPETITIVE LANDSCAPE

  • 9.1. KEY STRATEGIC DEVELOPMENTS
    • 9.1.1. MERGER & ACQUISITIONS
    • 9.1.2. PRODUCT LAUNCH & DEVELOPMENTS
    • 9.1.3. PARTNERSHIP, CONTRACT/AGREEMENT & COLLABORATION
    • 9.1.4. BUSINESS EXPANSION/ APPROVAL/ ANNOUNCEMENT
  • 9.2. COMPANY PROFILE
    • 9.2.1. ABBOTT LABORATORIES
    • 9.2.2. AGILENT TECHNOLOGIES INC
    • 9.2.3. BECTON, DICKINSON AND COMPANY (BD)
    • 9.2.4. BIOMERIEUX SA
    • 9.2.5. BIO-RAD LABORATORIES INC
    • 9.2.6. F. HOFFMANN-LA ROCHE
    • 9.2.7. ILLUMINA INC
    • 9.2.8. INSCRIPTA
    • 9.2.9. OXFORD NANOPORE TECHNOLOGIES LTD
    • 9.2.10. PACIFIC BIOSCIENCE
    • 9.2.11. PERKINELMER INC
    • 9.2.12. QIAGEN NV
    • 9.2.13. REGENERON PHARMACEUTICALS
    • 9.2.14. THERMO FISHER SCIENTIFIC INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - DIGITAL GENOME
  • TABLE 2: GLOBAL DIGITAL GENOME MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 3: GLOBAL DIGITAL GENOME MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 4: GLOBAL SEQUENCING AND ANALYZER INSTRUMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 5: GLOBAL SEQUENCING AND ANALYZER INSTRUMENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 6: GLOBAL DNA/RNA ANALYSIS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 7: GLOBAL DNA/RNA ANALYSIS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 8: GLOBAL SEQUENCING AND ANALYSIS SOFTWARE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 9: GLOBAL SEQUENCING AND ANALYSIS SOFTWARE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 10: GLOBAL SEQUENCING CHIPS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 11: GLOBAL SEQUENCING CHIPS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 12: GLOBAL SAMPLE PREP INSTRUMENTS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 13: GLOBAL SAMPLE PREP INSTRUMENTS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 14: GLOBAL DIGITAL GENOME MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 15: GLOBAL DIGITAL GENOME MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 16: GLOBAL DIAGNOSTICS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 17: GLOBAL DIAGNOSTICS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 18: GLOBAL DRUG DISCOVERY MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 19: GLOBAL DRUG DISCOVERY MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 20: GLOBAL ACADEMIC RESEARCH MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 21: GLOBAL ACADEMIC RESEARCH MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 22: GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 23: GLOBAL PERSONALIZED MEDICINE MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 24: GLOBAL AGRICULTURAL MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 25: GLOBAL AGRICULTURAL MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 26: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 27: GLOBAL OTHER APPLICATIONS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 28: GLOBAL DIGITAL GENOME MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 29: GLOBAL DIGITAL GENOME MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 30: GLOBAL DIAGNOSTICS AND FORENSIC LABS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 31: GLOBAL DIAGNOSTICS AND FORENSIC LABS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 32: GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 33: GLOBAL ACADEMIC RESEARCH INSTITUTES MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 34: GLOBAL HOSPITALS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 35: GLOBAL HOSPITALS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 36: GLOBAL OTHER END-USERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 37: GLOBAL OTHER END-USERS MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 38: GLOBAL DIGITAL GENOME MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 39: GLOBAL DIGITAL GENOME MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 40: NORTH AMERICA DIGITAL GENOME MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 41: NORTH AMERICA DIGITAL GENOME MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 42: LEADING PLAYERS OPERATING IN NORTH AMERICA DIGITAL GENOME MARKET
  • TABLE 43: EUROPE DIGITAL GENOME MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 44: EUROPE DIGITAL GENOME MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 45: LEADING PLAYERS OPERATING IN EUROPE DIGITAL GENOME MARKET
  • TABLE 46: ASIA PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 47: ASIA PACIFIC DIGITAL GENOME MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 48: LEADING PLAYERS OPERATING IN ASIA PACIFIC DIGITAL GENOME MARKET
  • TABLE 49: REST OF WORLD DIGITAL GENOME MARKET, BY REGION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)
  • TABLE 50: REST OF WORLD DIGITAL GENOME MARKET, BY REGION, FORECAST YEARS, 2021-2028 (IN $ MILLION)
  • TABLE 51: LEADING PLAYERS OPERATING IN REST OF WORLD DIGITAL GENOME MARKET

LIST OF FIGURES

  • FIGURE 1: CHRONIC CONDITIONS IN PATIENTS HOSPITALIZED WITH COVID-19 IN THE UNITED STATES
  • FIGURE 2: PORTER'S FIVE FORCE ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: KEY INVESTMENT INSIGHTS
  • FIGURE 6: GLOBAL DIGITAL GENOME MARKET, BY PRODUCT, IN 2020
  • FIGURE 7: GLOBAL DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYZER INSTRUMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 8: GLOBAL DIGITAL GENOME MARKET, BY DNA/RNA ANALYSIS, 2021-2028 (IN $ MILLION)
  • FIGURE 9: GLOBAL DIGITAL GENOME MARKET, BY SEQUENCING AND ANALYSIS SOFTWARE, 2021-2028 (IN $ MILLION)
  • FIGURE 10: GLOBAL DIGITAL GENOME MARKET, BY SEQUENCING CHIPS, 2021-2028 (IN $ MILLION)
  • FIGURE 11: GLOBAL DIGITAL GENOME MARKET, BY SAMPLE PREP INSTRUMENTS, 2021-2028 (IN $ MILLION)
  • FIGURE 12: GLOBAL DIGITAL GENOME MARKET, BY APPLICATION, IN 2020
  • FIGURE 13: GLOBAL DIGITAL GENOME MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)
  • FIGURE 14: GLOBAL DIGITAL GENOME MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)
  • FIGURE 15: GLOBAL DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH, 2021-2028 (IN $ MILLION)
  • FIGURE 16: GLOBAL DIGITAL GENOME MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)
  • FIGURE 17: GLOBAL DIGITAL GENOME MARKET, BY AGRICULTURAL, 2021-2028 (IN $ MILLION)
  • FIGURE 18: GLOBAL DIGITAL GENOME MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
  • FIGURE 19: GLOBAL DIGITAL GENOME MARKET, BY END-USER, IN 2020
  • FIGURE 20: GLOBAL DIGITAL GENOME MARKET, BY DIAGNOSTICS AND FORENSIC LABS, 2021-2028 (IN $ MILLION)
  • FIGURE 21: GLOBAL DIGITAL GENOME MARKET, BY ACADEMIC RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
  • FIGURE 22: GLOBAL DIGITAL GENOME MARKET, BY HOSPITALS, 2021-2028 (IN $ MILLION)
  • FIGURE 23: GLOBAL DIGITAL GENOME MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)
  • FIGURE 24: NORTH AMERICA DIGITAL GENOME MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 25: UNITED STATES DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 26: CANADA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 27: EUROPE DIGITAL GENOME MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 28: GERMANY DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 29: FRANCE DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 30: UNITED KINGDOM DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 31: ITALY DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 32: RUSSIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 33: BELGIUM DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 34: POLAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 35: REST OF EUROPE DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 36: ASIA PACIFIC DIGITAL GENOME MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 37: CHINA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 38: JAPAN DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 39: AUSTRALIA & NEW ZEALAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 40: INDIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 41: SOUTH KOREA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 42: THAILAND DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 43: INDONESIA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 44: VIETNAM DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 45: REST OF ASIA PACIFIC DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 46: REST OF WORLD DIGITAL GENOME MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
  • FIGURE 47: LATIN AMERICA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
  • FIGURE 48: MIDDLE EAST & AFRICA DIGITAL GENOME MARKET, 2021-2028 (IN $ MILLION)
Back to Top